Moreover, since CBD significantly decreases IL-10 production, we may conclude that treatments with CBD concentrations ranging from 1.0–1.0 μg/mL should be avoided in depression and probably in most immune and autoimmune disorders. Here, IL10 is linked to depressive symptom measurement.